Incentives for Executives and Employees Through the Issuance of Stock Acquisition Rights
First written in FY2017-Q2. 23 of 27 entries say "Advanced", first in FY2017-Q3. Latest entry: 2026-07-06.
- 2026-07-06AchievedShare Issuance and Disposal
「当社は、2026 年５月 15日開催の取締役会において決議いたしました、譲渡制限付株式インセンティブとしての自己株式の処分に関し、本日、下記のとおり、払込手続きが完了いたしましたのでお知らせいたします。」
2026年5月15日に決議した従業員持株会向け譲渡制限付株式の自己株式処分について、59,700株、処分総額160,055,700円の払込手続きが完了した。 - FY2026AdvancedAnnual report
「The 1,140 thousand-share decrease in common treasury shares resulted from the delivery of 1,076 thousand treasury shares upon the exercise of stock options and the delivery of 64 thousand treasury shares as restricted stock-based compensation.」
During the consolidated fiscal year, 1,076 thousand treasury shares were delivered upon the exercise of stock options, indicating progress in the exercise of rights under the incentive program for officers and employees. - FY2026-H1AdvancedAnnual report
「1 April 2025–30 September 2025 (Note) Increase due to the exercise of stock acquisition rights. 5,600 56,829,800 8 14,529 8 14,737」
During the interim period, the exercise of stock acquisition rights increased the total number of issued shares by 5,600 and increased both share capital and capital surplus by ¥8 million. - FY2025AdvancedAnnual report
「The 405 thousand-share increase in issued common shares resulted from the issuance of 405 thousand new shares upon the exercise of stock options.」
The company issued 405,200 new shares upon the exercise of stock options, increasing both share capital and capital surplus by ¥558 million. - FY2025-H1AdvancedAnnual report
「1 April 2024–30 September 2024 (Note) 1. Increase due to the exercise of stock acquisition rights. 1,000 56,420,000 1 13,964 1 14,172」
During the interim period, the exercise of stock acquisition rights increased the total number of issued shares by 1,000 and increased both share capital and capital surplus by ¥1 million. The company also disclosed an increase of 8,500 shares in October 2024. - FY2024-Q3AdvancedAnnual report
「In addition, the disposal of 441,800 treasury shares upon the exercise of stock options reduced treasury shares by ¥1,182 million during the nine-month period of the current consolidated fiscal year.」
The company disclosed the disposal of 441,800 treasury shares upon the exercise of stock options and a ¥1,182 million reduction in treasury shares. - FY2024-Q2AdvancedAnnual report
「Resolution date 31 July 2023 Categories and number of grantees Company directors 5 Executive officers 6 Company employees 297 Number of stock acquisition rights * 5,885 Number of underlying shares * 588,500 shares (Note 1) Exercise period * 1 August 2025 to 31 July 2030」
The company issued 5,885 stock acquisition rights, representing 588,500 underlying shares, to 5 directors, 6 executive officers and 297 employees, with an exercise period from August 2025 to July 2030. - FY2023-Q3AdvancedAnnual report
「In addition, the disposal of 365,100 treasury shares upon the exercise of stock options reduced treasury shares by ¥950 million during the nine-month period of the current consolidated fiscal year.」
The company disclosed the disposal of 365,100 treasury shares upon the exercise of stock options and a ¥950 million reduction in treasury shares. - FY2023-Q2AdvancedAnnual report
「Resolution date 29 July 2022 Categories and number of grantees Company directors 5 Executive officers 5 Company employees 279 Number of stock acquisition rights * 5,530 Number of underlying shares * 553,000 shares (Note 1) Exercise period * 30 July 2024 to 29 July 2029」
The company issued 5,530 stock acquisition rights, representing 553,000 underlying shares, to 5 directors, 5 executive officers and 279 employees, with an exercise period from July 2024 to July 2029. - FY2022AdvancedAnnual report
「The 504 thousand-share decrease in common treasury shares resulted from the delivery of treasury shares upon the exercise of stock options.」
During the consolidated fiscal year, 504 thousand treasury shares were delivered upon the exercise of stock options. - FY2022-Q3AdvancedAnnual report
「In addition, the disposal of 344,400 treasury shares upon the exercise of stock options reduced treasury shares by ¥855 million during the nine-month period of the current consolidated fiscal year.」
The company disclosed the disposal of 344,400 treasury shares upon the exercise of stock options and a ¥855 million reduction in treasury shares. - FY2022-Q2AdvancedAnnual report
「Resolution date 30 July 2021 Categories and number of grantees Company directors 3 Executive officers 6 Company employees 269 Number of stock acquisition rights * 5,140 Number of underlying shares * 514,000 shares (Note 1) Exercise period * 31 July 2023 to 30 July 2028」
The company issued 5,140 stock acquisition rights, representing 514,000 underlying shares, to 3 directors, 6 executive officers and 269 employees, with an exercise period from July 2023 to July 2028. - FY2021AdvancedAnnual report
「Company directors 7 Executive officers 4 Company employees 261 Common shares 541,000 shares Exercise period 1 August 2022 to 31 July 2027」
As 2020 stock options, 541,000 shares were granted to 7 directors, 4 executive officers and 261 employees, with an exercise period from August 2022 to July 2027. A total of 640,600 shares were exercised under existing stock options. - FY2021-Q3AdvancedAnnual report
「As a result of the exercise of stock options during the third quarter accounting period, the number of treasury shares held by the company was 574,600 as of 31 December 2020.」
The company disclosed that the number of treasury shares was 574,600 as of 31 December 2020 following the exercise of stock options. - FY2021-Q2AdvancedAnnual report
「Resolution date 31 July 2020 Categories and number of grantees Company directors 7 Executive officers 4 Company employees 261 Number of stock acquisition rights * 5,410 Number of underlying shares * 541,000 shares (Note 1) Exercise period * 1 August 2022 to 31 July 2027」
The company issued 5,410 stock acquisition rights, representing 541,000 underlying shares, to 7 directors, 4 executive officers and 261 employees, with an exercise period from August 2022 to July 2027. - FY2020-Q3AdvancedAnnual report
「In addition, the disposal of 518,400 treasury shares upon the exercise of stock options reduced treasury shares by ¥1,184 million during the nine-month period of the current consolidated fiscal year.」
The company disclosed the disposal of 518,400 treasury shares upon the exercise of stock options and a ¥1,184 million reduction in treasury shares. - FY2020-Q2AdvancedAnnual report
「The stock acquisition rights issued during the second quarter accounting period are as follows. Resolution date 31 July 2019 Categories and number of grantees Company directors 8 Executive officers 2 Company employees 248 Number of stock acquisition rights * 5,035 Number of underlying shares * 503,500 shares (Note 1) Exercise period * 1 August 2021 to 31 July 2026」
The company issued 5,035 stock acquisition rights, representing 503,500 underlying shares, to directors, executive officers and employees, with an exercise period from August 2021 to July 2026. - FY2019AdvancedAnnual report
「1 April 2018–31 March 2019 (Note) 218,800 28,209,500 397 13,962 397 14,171 (Note) 1. Increase due to the exercise of stock acquisition rights.」
During the fiscal year, the exercise of stock acquisition rights increased the total number of issued shares by 218,800 and increased both share capital and capital surplus by ¥397 million. In addition, 464,000 shares were granted to directors, executive officers and employees as 2018 stock options. - FY2019-Q3AdvancedAnnual report
「1 October 2018–31 December 2018 41,600 28,124,900 83 13,824 83 14,032 (Note) 1. Increase due to the exercise of stock acquisition rights. 2. Between 1 January 2019 and 31 January 2019, the exercise of stock acquisition rights increased the total number of issued shares by 13,900 and increased both share capital and capital surplus by ¥23 million.」
During the third quarter accounting period, the exercise of stock acquisition rights increased the total number of issued shares by 41,600 and increased both share capital and capital surplus by ¥83 million. In addition, in January 2019, the total number of issued shares increased by 13,900 and both share capital and capital surplus increased by ¥23 million. - FY2019-Q2AdvancedAnnual report
「The stock acquisition rights issued during the second quarter accounting period are as follows. Resolution date 30 July 2018 Categories and number of grantees Company directors 8 Executive officers 2 Company employees 233 Number of stock acquisition rights 4,640 Number of underlying shares 464,000 Exercise period 31 July 2020 to 30 July 2025」
The company issued 4,640 stock acquisition rights, representing 464,000 underlying shares, to directors, executive officers and employees. - FY2019-Q1AdvancedAnnual report
「1 April 2018–30 June 2018 (Note) 19,700 28,010,400 36 13,602 36 13,811 (Note) 1. Increase due to the exercise of stock acquisition rights.」
During the first quarter, the exercise of stock acquisition rights increased the total number of issued shares by 19,700 and increased both share capital and capital surplus by ¥36 million. The company also disclosed an increase of 7,600 shares in July 2018. - FY2018-Q3AdvancedAnnual report
「Between 1 January 2018 and 31 January 2018, the exercise of stock acquisition rights increased the total number of issued shares by 40,900, and increased both share capital and the capital surplus by ¥68 million.」
The company disclosed that the exercise of stock acquisition rights increased the total number of issued shares, share capital and capital surplus during the period before the filing date. - FY2018-Q2AdvancedAnnual report
「The stock acquisition rights issued during the second quarter accounting period were as follows.」
Pursuant to the resolution dated 31 July 2017, 4,475 stock acquisition rights were issued, representing 447,500 underlying shares, with an exercise period from 1 August 2019 to 31 July 2024. - FY2017-Q3AdvancedAnnual report
「As a result of the exercise of stock options and the acquisition of treasury shares during the third quarter accounting period, the number of treasury shares held by the company was 407,800 as of 31 December 2016.」
The company disclosed that the stock acquisition rights issued in the previous quarter had been exercised. - FY2017-Q2First statedAnnual report
「The stock acquisition rights issued during the second quarter accounting period were as follows.」
Pursuant to the resolution dated 29 July 2016, 4,240 stock acquisition rights were issued, representing 424,000 underlying shares, with an exercise period from 30 July 2018 to 29 July 2023.